Ammonia is a ubiquitous waste product of protein metabolism that can accumulate in numerous metabolic disorders, causing neurological dysfunction ranging from cognitive impairment to tremor, ataxia, seizures, coma and death 1 . The brain is especially vulnerable to ammonia as it readily crosses the blood-brain barrier in its gaseous form, NH 3 , and rapidly saturates its principal removal pathway located in astrocytes 2 . Thus, we wanted to determine how astrocytes contribute to the initial deterioration of neurological functions characteristic of hyperammonemia in vivo. Using a combination of two-photon imaging and electrophysiology in awake head-restrained mice, we show that ammonia rapidly compromises astrocyte potassium buffering, increasing extracellular potassium concentration and overactivating the Na + -K + -2Cl − cotransporter isoform 1 (NKCC1) in neurons. The consequent depolarization of the neuronal GABA reversal potential (E GABA ) selectively impairs cortical inhibitory networks. Genetic deletion of NKCC1 or inhibition of it with the clinically used diuretic bumetanide potently suppresses ammonia-induced neurological dysfunction. We did not observe astrocyte swelling or brain edema in the acute phase, calling into question current concepts regarding the neurotoxic effects of ammonia 3, 4 . Instead, our findings identify failure of potassium buffering in astrocytes as a crucial mechanism in ammonia neurotoxicity and demonstrate the therapeutic potential of blocking this pathway by inhibiting NKCC1.
Ammonia neurotoxicity is an almost universal phenomenon that occurs in all animals, from fish to humans 5 . Ammonia homeostasis is particularly important in the brain as equimolar amounts of NH 4 + are released with the excitotoxic neurotransmitter glutamate during neuronal firing 6 . In the brain, the enzyme that removes ammonia and glutamate, glutamine synthetase, has a higher affinity for ammonia than for glutamate 2, 7 . In the rest of the body, ammonia detoxification is centralized to the liver, and liver disease frequently leads to encephalopathy that is thought to be due to ammonia neurotoxicity. Mortality in ammonia-handling disorders is primarily due to acute episodes of elevated blood ammonia (hyperammonemia), characterized by stupor, seizures and coma 1 . However, ammonia was also recently identified as an independent contributor to seizure development in epileptic children with normal liver function 8 . To understand this phenomenon, we here studied the direct effects of ammonia on intact nervous tissue. This approach avoided both the adaptive changes associated with chronic exposure and also any ammoniaindependent pathology accompanying overt liver failure 9, 10 .
OTC deficiency is a childhood urea cycle disorder characterized by a reduced ability to metabolize ammonia to urea in the liver 1 . To induce acute ammonia intoxication, we injected awake adult ornithine transcarbamylase (OTC)-deficient (Otc spf-ash ) mice intraperitoneally (i.p.) with ammonia (ammonium chloride or ammonium acetate, 7.5 mmol kg −1 ) ( Fig. 1a) 9 . Shortly after the injection, we recorded a rapid increase in the extracellular ammonia concentration ([NH 4 + ] o ) in the brain from 0.54 ± 0.18 mM to 4.83 ± 0.52 mM and in plasma from 0.32 ± 0.07 mM to 4.21 ± 0.59 mM ( Supplementary Fig. 1a,b) . We employed several behavioral measures to track the progression and severity of ammonia neurotoxicity. Automated video tracking revealed an early decrease in spontaneous movement (13.69 ± 1.48 m min −1 Otc spf-ash control versus 0.42 ± 0.22 m min −1 Otc spf-ash ammonia i.p.) ( Fig. 1b) . We also developed a phenotype severity score examining hyperacusis, imbalance, ataxia, tremor and level of consciousness that allowed us to track the rapid onset of neurological dysfunction (0.53 ± 0.28 Otc spf-ash control versus 9.00 ± 0.46 Otc spf-ash ammonia i.p.; a score of 0 represents normal function and 11 deep coma) ( Fig. 1c) 9 . Similar to children with inborn OTC deficiency, the Otc spf-ash mice also displayed impaired learning at baseline compared to wild-type mice, tested using contextual fear conditioning. This finding probably reflects the baseline excess of [NH 4 + ] o in Otc spf-ash mice (0.32 ± 0.07 mM in plasma) as compared to wild-type mice (0.074 ± 0.014 mM in plasma) ( Fig. 1d and Supplementary Fig. 1c ) 1, 9, 11 .
In addition to cognitive, sensory and motor impairment, children with OTC deficiency typically develop myoclonic and other types of generalized seizures during episodes of hyperammonemia 1 . Around the time of weaning, Otc spf-ash mice also developed spontaneous myoclonic seizures, which are brief (<2 s) involuntary jerky movements l e t t e r s 1 6 4 4 VOLUME 19 | NUMBER 12 | DECEMBER 2013 nature medicine caused by cortical seizure activity 9 . We injected ammonia to precipitate a more severe seizure phenotype and found that intermediate doses of ammonia (5-7.5 mmol kg −1 ) triggered numerous myoclonic seizures, whereas a lethal dose (10 mmol kg −1 ) induced longer lasting generalized tonic-clonic seizures ( Fig. 1e and Supplementary Video 1). We found that the frequency of myoclonic seizures closely correlated with overall phenotype severity. The neurological phenotype was also entirely masked by anesthesia, emphasizing both the clinical relevance of our model and the need for recordings in awake animals (pooled data for isoflurane 1.5%, ketamine 0.12 mg per g body weight with xylazine 0.01 mg per g body weight and urethane 1.25 mg per g body weight) ( Fig. 1f) . We next asked whether a primary dysfunction of astroglia might mediate the neurotoxic effects of ammonia. Astrocytes express glutamine synthetase, the primary enzyme necessary for ammonia detoxification, and are consequently subject to more than four times as much ammonia influx than any other cell type in the brain 12 . The current literature suggests that astrocyte swelling and brain edema are necessary for ammonia neurotoxicity, but consist mainly of ex vivo and post-mortem studies in the late stage of hepatic encephalopathy 2 . Using in vivo two-photon imaging, we instead found that i.p. ammonia injection was associated with a transient astrocyte shrinkage of 4.61 ± 0.72% and 5.04 ± 0.84% in wild-type and Otc spf-ash mice, respectively, lasting from 10 to 30 min after the injection ( Fig. 2a,b) 4, 13 . A lethal dose of ammonia was necessary to elicit brain edema (10 mmol kg −1 i.p. in vivo) and astrocyte swelling (50 mM in situ) ( Supplementary  Fig. 1d,e) 10 . Additionally, deletion of Aqp4, encoding the astrocyte water channel aquaporin-4, did not ameliorate the seizures, neurological dysfunction, brain edema or increase in ammonia ( Supplementary  Fig. 1f ) 14, 15 . We then tested the effect of ammonia neurotoxicity on the principal mode of astrocyte signaling: intracellular calcium transients. We found that injection of ammonia caused increased and desynchronized astrocyte calcium signaling, which was temporally correlated with seizure activity (calcium transient frequency 2.67 ± 0.36 mHz per cell Otc spf-ash control versus 9.03 ± 1.16 mHz per cell Otc spf-ash ammonia i.p.) ( Fig. 2c, Supplementary Videos 2 and 3 and Supplementary Fig. 1g -i) 16 .
Since the widespread increase in astrocyte calcium signaling did not appear to be due to swelling 15 , we next asked whether it might be linked to the interference of ammonia with potassium transport previously described in cell culture and the kidney 4, 6, 17, 18 . Using NH 4 + ion-and K + ion-sensitive microelectrodes (ISMs) 19 in awake Otc spf-ash mice, we found that i.p. ammonia injection increased the extracellular potassium concentration ([K + ] o ) in the cerebral cortex by 1.93 ± 0.19 mM (adjusted for ionic interference 17 , Fig. 2d ). As previous studies and our results indicate that the bulk of ammonia neurotoxicity occurs in cortical gray matter ( Supplementary Fig. 2a ) 2, 20 , we next applied ammonia directly on the cortex of awake wild-type mice. The ammonia dose was titrated in initial experiments to achieve a [NH 4 + ] o increase to 5.82 ± 0.18 mM, which was similar to our observations from systemic toxicity and sufficient to reproduce the seizure phenotype ( Supplementary Table 1 ). We also found that cortical ammonia intoxication in wild-type mice increased [K + ] o by 2.24 ± 0.17 mM from a resting level of 3.91 ± 0.27 mM (pooled control data) ( Fig. 2e and Supplementary Fig. 2b-d) . The [K + ] o increase following both i.p. injection and cortical superfusion of ammonia strongly correlated with (R 2 0.583 and 0.808, respectively) and consistently preceded (seizure onset 4.91 ± 0.35 min and 2.88 ± 0.20 min, respectively) myoclonic seizures and recovered upon washout as the neurological manifestations subsided ( Fig. 2f) . Conversely, the pH effects of ammonia in the cortex were mild and delayed and correlated poorly with clinical phenotype (Supplementary Fig. 2e ).
Having established that ammonia increases [K + ] o sufficiently to cause neurological dysfunction in vivo, we wondered whether the npg excess NH 4 + load on astrocyte membranes impairs potassium buffering by inhibiting transport or by directly competing for uptake. The gradients driving astrocyte uptake of potassium are largely dependent on Na + -K + ATPase (NKA) activity, especially in the context of sustained [K + ] o elevations 17, 21, 22 . By incubating cultured wild-type astrocytes with biologically relevant concentrations of ammonia (0.5-10 mM), we observed a dose-dependent reduction in NKA-mediated (ouabain-sensitive) potassium analog rubidium ( 86 Rb + ) uptake ( Fig. 2g and Supplementary Fig. 2f ) 21 . We then substituted KCl with NH 4 Cl in a cell-free assay derived from cultured astrocytes. We found that NH 4 Cl alone was able to maintain normal NKA activity ( Fig. 2g) , which indicates that NH 4 + competes with K + for transport. Notably, NH 4 + and K + ions have a comparable hydrated radius and charge 6 . To test whether the [K + ] o increase alone is sufficient to reproduce the phenotype of ammonia neurotoxicity in vivo, we superfused KCl (12.5 mM) across the cortex of awake wild-type mice. The KCl superfusion increased [K + ] o by 2.37 ± 0.03 mM and caused the mice to develop myoclonic seizures on a similar timescale to those seen in wild-type mice exposed to cortical ammonia application ( Fig. 2h) . Combined, our observations indicate that ammonia short-circuits potassium transport in astrocytes and that the consequent increase in [K + ] o alone is sufficient to cause the neurological dysfunction. Given that astrocyte calcium transients potently stimulate NKA activity 21 , hyperammonemia increases NKA activity 13 and increased NKA pumping causes cell shrinkage (3 Na + export versus 2 K + import), we speculate that our imaging observations represent compensatory changes in astrocytes to buffer the excess substrate ([NH 4 + ] o and [K + ] o ) ( Fig. 2i ). How does impaired astrocyte potassium buffering lead to neurological dysfunction and seizures? Previous ex vivo studies have generated numerous conflicting hypotheses about the effect of ammonia on neurotransmission [23] [24] [25] . To explore whether excess ammonia and potassium might cause neurological dysfunction by impairing cortical inhibition 26, 27 , we employed paired-pulse whisker stimulation in awake wild-type mice. This paradigm elicits two successive field excitatory post-synaptic potentials (fEPSPs), where the second fEPSP has lower amplitude primarily owing to the activation of cortical inhibitory networks (quantified by a paired-pulse ratio, PPR < 1) 28 . We found that cortical ammonia or potassium application impaired cortical inhibition, as illustrated by an increased PPR from 0.64 ± 0.13 (control) to 1.56 ± 0.24 (ammonia) and 1.48 ± 0.22 (potassium), which recovered to 0.61 ± 0.15 (washout) ( Fig. 3a) .
To further explore the link between impaired astrocyte potassium buffering and neuronal disinhibition we patched pyramidal neurons in acute cortical slices from wild-type mice. GABA is the main inhibitory neurotransmitter in the brain, and its inhibitory action on GABA A receptors is dependent on a hyperpolarized E GABA 29 . Our initial experiments showed that adding 7 mM ammonia to the perfusate reproduced the increase in [NH 4 + ] o and [K + ] o observed in vivo (3.67 ± 0.53 mM and 1.88 ± 0.13 mM, respectively) ( Fig. 3b) . Next, using whole-cell recordings and GABA application we found that ammonia depolarized E GABA by +12.33 ± 3.66 mV ( Fig. 3c-e npg was GABA A receptor dependent as the GABA A receptor antagonist bicuculline completely blocked the GABA-induced current (Fig. 3f) , but was not associated with any significant change in neuronal resting membrane potential or input resistance 25 .
A hyperpolarized E GABA depends on the balance of chloride transport by NKCC1 and K + -2Cl − cotransporter isoform 2 (KCC2) 29 . KCC2 deletion in mice is known to cause lethal seizures immediately after birth as a result of excess chloride import via NKCC1 (ref. 30) . Conversely, deletion of the NKCC1 isoform gene Slc12a2, which is widely expressed in neurons and secretory epithelia, is associated with normal inhibitory GABA-ergic function 31, 32 . NKCC1 is thus the principal chloride importer in neurons, and inhibition, knockout or knockdown of this transporter has been shown to treat temporal lobe, hypoglycemic, febrile and neonatal seizures by ensuring a hyperpolarized E GABA 26, 27, [31] [32] [33] [34] . Therefore, we next tested the therapeutic effect of the diuretic bumetanide, a highly specific NKCC1 inhibitor at low concentrations 26, 27, 35 . In our study, bumetanide treatment successfully prevented the depolarizing effect of ammonia on E GABA (Fig. 3d,e) . To ensure the molecular specificity of bumetanide, we also performed gramicidin-perforated patch recordings in constitutive NKCC1 knockout (Slc12a2 −/− ) mice and wild-type (Slc12a2 +/+ ) littermates. NKCC1 deletion completely blocked the depolarizing effect of ammonia on E GABA (+11.14 ± 1.22 mV in wild-type mice and +1.00 ± 1.07 mV in Slc12a2 −/− mice) ( Fig. 3g,h) . In support of our observations, previous in vivo, in situ and in vitro work has shown that neurons exposed to elevated ammonia or potassium levels have increased intracellular chloride content 36, 37 . Using immunohistochemistry of NKCC1-knockout and wild-type mice, we found that NKCC1 is expressed in adult cortex (Fig. 3i) , confirming previous studies showing NKCC1 expression in adult brain, although at lower levels than in developing tissue 26, 38 . We also observed no obvious differences in the expression pattern of NKCC1 between wild-type and Otc spf-ash mice. Taken together, our observations indicate that elevated [NH 4 + ] o and [K + ] o promote overactivation of neuronal NKCC1, leading to a depolarization of E GABA , impaired cortical inhibition and seizures (Fig. 3j) .
We next explored potential treatments for ammonia neurotoxicity (Fig. 4a) . It has previously been suggested that reducing ammonia influx into astrocytes by inhibiting glutamine synthetase can improve clinical outcome 3 . However, in awake intact animals we found that this strategy worsened the neurological phenotype by increasing the overall [NH 4 + ] o and [K + ] o load on neurons (Supplementary Fig. 3a-c) . Similarly, blocking ammonia import into glia via potassium transporters would also promote seizure development 17, 22 . Instead, we hypothesized that inhibiting NKCC1 overactivation would be the most effective strategy, as this disrupts the vicious cycle of ammoniainduced disinhibition, excess neuronal firing and further potassium and ammonia release. Using the previously described paired-pulse paradigm, we found that bumetanide significantly improved cortical disinhibition when applied with either the cortical ammonia or potassium superfusion (PPR 0.88 ± 0.15 after ammonia and bumetanide application, PPR 0.59 ± 0.17 after washout of both, PPR 0.92 ± 0.18 after potassium and bumetanide) in wild-type mice ( Fig. 4b and  Supplementary Fig. 3d ). NKCC1 inhibition also increased spontaneous movement in mice (from 0.42 ± 0.22 m min −1 to 3.17 ± 0.46 m min −1 ), reduced the phenotype severity score (from 9.00 ± 0.46 to 6.00 ± 0.72) and decreased myoclonic seizure frequency (from 0.78 ± 0.05 seizures per minute to 0.13 ± 0.03 seizures per minute with cortical potassium, 1.02 ± 0.07 seizures per minute to 0.10 ± 0.02 seizures per minute with cortical ammonia and 2.66 ± 0.14 seizures per minute to 0.32 ± 0.02 seizures per minute with i.p. ammonia) ( Fig. 4c,d) . Moreover, survival of Otc spf-ash mice after an ammonia overdose (10 mmol kg −1 ) increased by a factor of 3.87 (hazard rate ratio: 0.26, 95% confidence interval: 0.08-0.87) (Fig. 4e) . These improvements were observed both when bumetanide was administered systemically (30 mg per kg body weight administered with ammonia i.p. in Otc spf-ash mice) and cortically (5 µM co-applied with ammonia on the cortex in wild-type mice). Bumetanide is also routinely used in clinical practice, has a favorable side-effect profile 35 and is estimated to have ~33% blood-brain barrier penetration 39 . Moreover, the therapeutic effect of bumetanide could not be attributed to a normalization of [K + ] o , [NH 4 + ] o or brain glutamine concentration, which were unaltered by the treatment in both wild-type and Otc spf-ash mice (Supplementary Table 2 and Supplementary Fig. 3e,f) .
In summary, we demonstrate that the immediate neurotoxic effects of ammonia are dependent on a dysfunction of glial and neuronal cells involving two crucial steps. First, ammonia competitively impairs astrocyte potassium buffering to such an extent that the resultant increase in [K + ] o (~2 mM) alone is sufficient to induce neurological dysfunction and seizures in awake animals. Second, excess [NH 4 + ] o and [K + ] o promotes overactivation of neuronal NKCC1, which compromises inhibitory neurotransmission in the cortex. Deletion or selective inhibition of NKCC1 attenuates the neurological manifestations of acute ammonia intoxication. Additionally, our results bring into question the contribution of astrocyte swelling and brain edema to the onset of ammonia-induced neurological dysfunction. The use of awake mice proved crucial, as general anesthetics masked the clinical phenotype 16 . Our study thus provides a framework to further explore the clinical potential of NKCC1 inhibitors in treating the broad range of debilitating disorders of ammonia handling. Studies are also needed to investigate the role of this pathway in disorders characterized by chronic hyperammonemia and cognitive impairment.
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Mice and breeding. Otc spf-ash B6C3-F1, Glt1-eGFP BAC, Slc12a2 −/− SVJ129/ blksw and Aqp4 −/− C57BL/6J mice were bred as described previously 9, 15, 32, 40 .
For in vivo experiments, males from 8-12 weeks of age were used. Otc spf-ash mice were crossed with Glt1-eGFP mice for imaging experiments. Wild-type littermates of the appropriate strain were either bred or obtained from Jackson Laboratories, along with Wistar rat pups (for neuronal cell cultures). All animal experiments were approved by the Animal Care and Use Committee of the University of Rochester.
Behavioral characterization. We developed a phenotype severity score to quantify the degree of ammonia neurotoxicity based on previous studies 9, 41, 42 .
Each animal was scored every 5-15 min for the following phenotypes: hyperacusis (0-2), imbalance (0-3), ataxia/tremor (0-3) and level of consciousness (0-3). A maximum score of 11 represents deep coma (no corneal reflex), whereas 0 represents normal wakefulness. Hyperacusis was scored as 0 if the mouse did not display a startle response to 30-60 dB sound, 1 if the mouse responded to only 60 dB and 2 if it responded to 30 dB, too. Imbalance was scored using a ledge test, and the mice were given a score of 0 if they balanced on the ledge and let themselves down in a controlled fashion, 1 if they lost their footing while walking on the ledge, 2 if they did not effectively walk on or let themselves down from the ledge and 3 if they were unable to walk or get down from the ledge or simply fell off. Ataxia/tremor was scored using a gait test, where the mouse was encouraged to walk for a short distance. The mouse was scored 0 if it walked effectively, 1 if it had a slight tremor, 2 if it had a broad-based gait or severe tremor and 3 if it dragged its abdomen on the ground or was unable to walk. Consciousness was scored as 0 for awake, 1 for loss of scatter reflex, 2 for loss of righting reflex (LORR) and 3 for loss of corneal reflex. Automated movement analysis was performed using AnyMaze software analysis of CCD-camera recordings in a standard mouse cage. To analyze cognitive abilities, two commercial conditioning chambers (H10-11M-TC, Coulbourn Instruments) were adapted for contextual fear conditioning. Over the course of 4 d, mice were trained via a tone/shock protocol and trained to fear contextual and auditory cues [43] [44] [45] . Better-trained mice exhibited higher percentages of time during a 5-min trial freezing in the presence of auditory or contextual cues.
Animal preparation for awake in vivo recordings. Mouse preparation was modified from published protocols 10, 46 . Briefly, mice were anesthetized using isoflurane (1.5% mixed with 1-2 L min −1 O 2 ), head restrained with a custom-made miniframe and habituated to the restraint over 2 d in multiple sessions, with a total training duration of 3-4 h. A 1.5-mm craniotomy was then opened over the somatosensory cortex (1.5 mm in diameter, 3 mm lateral and 1.5 mm posterior to the bregma), the dura was carefully removed and the mice were allowed 60 min recovery before conducting the experiments. The craniotomy procedure lasted <20 min to minimize anesthesia exposure on the recording day. Animals were then head-restrained, placed in a behavioral tube to minimize movement and relocated to the imaging room, which was kept dark and quiet. Body temperature was maintained with a heating pad. For systemic drug treatment, a polyethylene intraperitoneal (i.p.) catheter was surgically implanted using a Seldinger technique to deliver drugs accurately and with minimal manipulation. For cortical drug application, artificial cerebrospinal fluid (aCSF) was perfused across the cortex of awake mice at a rate of 2 mL min −1 , into a custom-made well with ~200 µL volume, through tubing with ~100 µL volume, meaning the entire volume bathing the brain was exchanged every ~9 s. The aCSF solution contained (in mM) 126 NaCl, 2.5 KCl, 1.25 NaH 2 PO 4 , 2 MgCl 2 , 2 CaCl 2 , 10 glucose and 26 NaHCO 3 , pH 7.4. For imaging, calcium indicator rhod-2 AM (Invitrogen, 2 mM) was loaded onto exposed cortex for 30-40 min before application of agarose (1.5%, type III-A, Sigma) and a coverslip 15 .
Electrophysiological recordings. In vivo and in situ recordings were obtained from layer II somatosensory cortex, and coronal cortical slices were prepared from mice at 21-30 d after birth. Ion-sensitive microelectrodes (ISMs) for K + , NH4 + and H + were pulled from double-barreled pipette glass (PB150-6, WPI) with a tip diameter of 1-3 µm. The pipettes were silanized (coated) with dimethylsilane I (Fluka, Sigma) and filled with either K + ionophore I cocktail B (Fluka, selectivity coefficient −1.8 log(K + /NH 4 + )), NH4 + ionophore I cocktail B (Fluka, −0.9 log(NH 4 + /K + )) or H + ionophore I cocktail A (Fluka, Sigma). The backfill solutions for the K + , NH4 + and H + ISMs were 0.15 M KCl, 0.5 M NH 4 Cl and phosphate-buffered saline (PBS) with a pH of 7.4, respectively. The reference barrels were used to record the DC potentials and were filled with 0.15 M NaCl. In selected experiments, single-barrel electrodes were also used in combination with single-reference electrodes placed within 50 µm of each other. All ISMs were calibrated before and after each experiment using standard solutions (a <5% difference was acceptable), and the calibration data were fitted to the Nikolsky equation to determine electrode slope and interference 19 . K + and NH 4 + ISM traces were subtracted for ionic interference calculated by cross-calibrating the electrodes before use 17 . K + calibrations were done in 150 mM NaCl that contained doubling steps of K + over a range of concentrations appropriate for the experiment, usually 3-48 mM. NH4 + calibrations were carried out in 150 mM NaCl and aCSF from 0.1 mM to 10 mM to determine the sensitivity during the in vivo environment. H + calibrations were carried out in phosphate buffers from pH 5 to pH 9, where >90% had a response time of 1-5 s and a 51-to 59-mV response to 1 pH unit change.
Whole-cell and gramicidin perforated patch-clamp recordings were performed as described previously 27, 47 . Briefly, for whole-cell recordings we used electrodes with 3-5 MΩ resistance and an intracellular solution containing 135 mM K-methylsulfate, 10 mM KCl, 10 mM HEPES, 5 mM NaCl, 2.5 mM Mg-ATP, 0.3 mM Na-GTP (pH 7.3) and Alexa Fluor 350 (Invitrogen). Gramicidin perforated patch electrodes were filled with stock gramicidin (Sigma, 25 mg ml −1 in DMSO), which was diluted to a final concentration of 50 µg ml −1 in solution containing 130 mM KCl, 5 mM NaCl, 0.4 mM CaCl 2 , 1 mM MgCl 2 , 1.1 mM EGTA and 10 mM HEPES. Electroencephalogram (EEG) signals were externally filtered at 6 Hz (Filter Butterworth Model by Encore, Axopatch 200B by Axon Instruments), bandpass filtered at 1-100 Hz and digitized (Digidata 1440A by Axon Instruments). ISM signals were amplified (FD223a by WPI) and externally filtered and digitized as above, and reference field potential traces were subtracted. In selected experiments, wireless electromyogram (EMG) and electroencephalogram (EEG) electrodes were implanted (DSI Physiotel), and an extracellular microelectrode was placed in the thalamus (ventrobasal complex). Recordings were analyzed offline using pClamp 10.2. Myoclonic seizures were defined on the EEG as single or multiple 3-9 Hz polyspike and wave discharges (SWD) of 0.2-2 s duration associated with myoclonic jerks determined by video recording, EMG and direct observation. Whisker stimulation was delivered using a picospritzer III (Parken Instrumentation) and Master 8 (A.M.P.I.). Stimuli consisted of paired 50-µs air pulses with an interstimulus interval of 150 ms, and paired-pulse ratio (PPR) was calculated as previously described 28 . All solutions were pH (7.4) and osmolarity adjusted.
Two-photon laser scanning microscopy. A Mai Tai laser (SpectraPhysics)
attached to a confocal scanning system (Fluoview 300, Olympus) and an upright microscope (IX51W) was used. In vivo volume changes and calcium activity were imaged in the cortex 100 µm below the pial surface as described before 15, 16 , using 60× (1.1NA) and 20× (0.95NA) lenses, respectively. For in vivo volumetry, we collected XYZT image series (z step 1.5 µm, every 5 min) with acquisition time <20 s and laser power <40 mW. For in vivo calcium imaging, we collected dual-channel (rhod-2 and eGFP) frames at 0.2 or 1 Hz. A low sampling rate and <20 mW laser were also used here to avoid photodamage. A calcium transient was defined as an event where the relative ratio between the rhod-2 and eGFP signal intensities (∆F/F 0 ) was >2 s.d. (σ) from baseline. Beginning and end were defined as ∆F/F 0 > 0.5 σ and < 0.5 σ, respectively. Amplitude was taken as the peak ∆F/F 0 in this interval. For in situ volumetric imaging, acute cortical slices were loaded with Texas red hydrazide (1.5 µM, a fixable sulforhodamine 101 derivative) in aCSF for 50 min. Volume and calcium recordings were analyzed using previously described custom-made software (Matlab) 15 .
Cell culture assays. Cultured neocortical astrocytes and neurons were prepared from mouse and rat pups, respectively, 1-2 d after birth as previously described 21, 48 . For 86 Rb + experiments, the cultures were incubated for 10 min with or without ouabain (1 mM). The potassium analog 86 Rb + was then added npg to each well plate for 15 min in the presence of different NH 4 Cl concentrations (0-10 mM) (1 µCi, PerkinElmer). The reaction was stopped by placing the cells on ice and washing with ice-cold aCSF. The cells were lysed, and 86 Rb + uptake was quantified by liquid scintillation counting (Beckman Coulter). For Na + -K + ATPase activity, astrocyte cultures were used as previously described, and enzyme activity was quantified using the malachite green reaction (Sigma) and analyzed using spectrophotometry 49 .
Immunohistochemistry. Mice were anesthesized and perfused transcardially with 4% paraformaldehyde, and the brains were post-fixed overnight. Serial 16-µm sagittal cryostat sections were cut after overnight cryoprotection in 30% sucrose. Sections were incubated with goat anti-NKCC1 primary antibody (1:200, Santa Cruz Biotechnology, sc-21547) overnight at 4 °C, followed by incubation with an Alexa-488-conjugated donkey anti-goat secondary antibody (1:500, Invitrogen, A-11055). Vectashield containing DAPI (Vector) was used for mounting. Images were taken with a 10× lens in a BX53 Olympus system microscope attached to a DP72 Olympus digital camera.
Biochemical and hemodynamic analyses. Plasma ammonia analysis was performed on blood samples collected using 50-µL heparinized tubes from the femoral artery. An l-glutamate dehydrogenase-based kit (Sigma) was used for the quantification of ammonia in plasma 50 . For hemodynamic recordings, an intracranial pressure probe (Millar) was inserted through a small 0.5-mm craniotomy over the somatosensory cortex. Cerebral blood flow was assessed using a fiberoptic laser Doppler probe (PF5010, Perimed) and connected to an infrared laser Doppler flowmeter 51 . Blood pressure was monitored through the femoral artery cannula (SYS-BP1, WPI), and cerebral perfusion pressure was deduced by subtracting ICP from blood pressure 52 . All signals were digitized (Digidata 1332A, Axon Instruments) and analyzed (pClamp 10.2). Brain water content was assessed using wet-to-dry ratios of brain weight as described previously 53 . For 1 H-NMR, mouse forebrains were extracted, frozen with liquid nitrogen and homogenized in 7.5 mL 12% PCA at 0 °C using a microsonicator. The homogenate was centrifuged at 25,000g for 15 min, and the supernatants were neutralized to pH 7.0 with KOH over an ice bath. A further 15-min centrifugation (25,000g) separated the resultant KClO 4 , and the supernatant was lyophilized before being reconstituted with 0.65 ml deuterated water, as described previously 54 . 1 H-NMR spectra were acquired at 25 °C using a 600-mHz Varian UnityINOVA spectrometer equipped with a triple-axis gradient HCN probe. Signals were acquired following a 90° pulse with a 7,200 Hz spectral width and 32,000 data points. The time between pulses was 15 s, and 64 signals were averaged for each spectrum. Integrals of the relevant peaks were converted to µmol/g wet weight and normalized to NAA (methyl) to increase intersample consistency.
Statistical analyses. All analyses were performed using SPSS 19 software (IBM), and all tests were two-tailed where significance was achieved at α = 0.05 level. Where n ≥ 10 for normally distributed data, an unpaired t test (fewer than or equal to two variables) or ANOVA (more than two variables) were used for independent samples, and paired t test for paired samples. Where n < 10 or the data were non-normally distributed, we employed nonparametric tests including Mann-Whitney U (fewer than or equal to two variables) or Kruskall-Wallis (more than two variables) for independent samples and Wilcoxon signed-ranks test for paired samples. Overdose survival was compared using a Cox regression model (controlling for the potential confounding effect of mouse weight and age).
